Overview Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients Status: Recruiting Trial end date: 2023-06-01 Target enrollment: Participant gender: Summary This is a prospective randomized study compared with active control and placebo arms. Phase: Phase 1/Phase 2 Details Lead Sponsor: Taejoon Pharmaceutical Co., Ltd.